
Orexin B
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
Orexin B (hypocretin-2) is a hypothalamic neuropeptide that, together with Orexin A, governs arousal and the sleep-wake cycle. It shows a preference for the OX2 receptor.
| Test | Result | Status |
|---|---|---|
| Purity | 98.6% | Passed ✓ |
| Test | Result | Status |
|---|---|---|
| Purity | 98.5% | Passed ✓ |
Research Information
Orexin B is studied for its preferential OX2-receptor signaling and its contributions to wakefulness, feeding and arousal pathways, helping researchers dissect the distinct roles of the two orexin receptors in neuroscience research. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption.
Orexin B Research & Studies
What is Orexin B?
Orexin B, also designated hypocretin-2, is a 28-amino-acid neuropeptide synthesized mainly within lateral hypothalamic neurons. Together with Orexin A it constitutes the orexin system that laboratory investigators examine for its influence on arousal circuitry and sleep-wake transitions. Synthetic Orexin B is employed in controlled in-vitro preparations to map neuropeptide signaling because of its documented preference for the OX2 receptor.
Mechanism of Action
Orexin B binds preferentially to the OX2 receptor (HCRTR2), a G-protein-coupled receptor that couples primarily through Gq proteins. Receptor engagement elevates intracellular calcium and activates downstream kinase cascades in transfected cell lines and primary neuronal cultures. This OX2 selectivity contrasts with the dual OX1/OX2 activity of Orexin A, enabling researchers to isolate OX2-dependent second-messenger pathways under defined experimental conditions.
Primary Areas of Research
Investigators use Orexin B to dissect OX2-selective contributions to wakefulness, energy-homeostasis, and feeding-related hypothalamic circuits. Comparative receptor-binding and calcium-flux assays with Orexin A clarify the distinct functional roles of the two orexin receptors. Additional work focuses on how OX2 signaling modulates neuronal excitability within arousal and metabolic networks in isolated tissue and cell-based model systems.
Key Research Findings
Radioligand and functional assays consistently demonstrate higher affinity of Orexin B for OX2 than for OX1 receptors. Electrophysiological recordings in neuronal preparations show that OX2 activation by Orexin B increases excitatory drive linked to arousal-state maintenance. These observations establish Orexin B as a selective pharmacological tool for separating OX2-mediated responses from dual-receptor effects in neuroscience research.
Research Handling & Considerations
Orexin B is supplied exclusively for in-vitro and laboratory research applications. Investigators should reconstitute the peptide under sterile conditions, store aliquots at recommended low temperatures, and verify activity with validated receptor assays. All experimental work remains confined to controlled cell-culture or tissue-preparation systems and does not extend beyond laboratory research use.
Frequently Asked Questions
Orexin B shows preferential binding and signaling through the OX2 receptor, allowing selective investigation of OX2 pathways in receptor-expressing cell lines and related model systems.
Explore Other High-Purity Peptides

Epithalon

DSIP

Selank
